PMID
Article Title
Citation
Organization
Download
View Data
Synthesis and in vitro pharmacology of novel heterocyclic muscarinic ligands.

Farmaco 58: 739-48 (2003)
Universit&Aagrove
SAR analysis of adenosine diphosphate (hydroxymethyl)pyrrolidinediol inhibition of poly(ADP-ribose) glycohydrolase.

J Med Chem 46: 4322-32 (2003)
University of Kentucky
The combi-targeting concept: chemical dissection of the dual targeting properties of a series of"combi-triazenes".

J Med Chem 46: 4313-21 (2003)
Mcgill University Health Center/Royal Victoria Hospital
Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.

J Med Chem 46: 4297-312 (2003)
Pharmacia
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation.

J Med Chem 46: 4287-96 (2003)
Università
Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.

J Med Chem 46: 4273-86 (2003)
The University of Toledo
A specific mechanism of nonspecific inhibition.

J Med Chem 46: 4265-72 (2003)
Northwestern University
Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins.

J Med Chem 46: 4259-64 (2003)
Institute
Oxidosqualene cyclase inhibitors as antimicrobial agents.

J Med Chem 46: 4240-3 (2003)
University of Utah
Fragment screening and assembly: a highly efficient approach to a selective and cell active protein tyrosine phosphatase 1B inhibitor.

J Med Chem 46: 4232-5 (2003)
Abbott Laboratories

